Lion Point Capital
Latest statistics and disclosures from Lion Point Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PRAX, MLTX, RPRX, MIST, GERN, and represent 33.20% of Lion Point Capital's stock portfolio.
- Added to shares of these 3 stocks: CMPS, HUMA, MIST.
- Reduced shares in these 4 stocks: DAWN, VTYX, NERV, MRSN.
- Sold out of its positions in DAWN, MRSN, NERV, VTYX.
- Lion Point Capital was a net seller of stock by $-620k.
- Lion Point Capital has $17M in assets under management (AUM), dropping by -13.41%.
- Central Index Key (CIK): 0001643354
Tip: Access up to 7 years of quarterly data
Positions held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Lion Point Capital
Lion Point Capital holds 35 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Praxis Precision Medicines I Com New (PRAX) | 8.6 | $1.4M | 4.5k | 322.19 |
|
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 7.5 | $1.3M | 68k | 18.64 |
|
|
| Royalty Pharma Shs Class A (RPRX) | 6.1 | $1.0M | 21k | 47.97 |
|
|
| Milestone Pharmaceuticals (MIST) | 5.8 | $976k | +8% | 820k | 1.19 |
|
| Geron Corporation (GERN) | 5.1 | $861k | 578k | 1.49 |
|
|
| Syndax Pharmaceuticals (SNDX) | 5.0 | $841k | 36k | 23.36 |
|
|
| Ardelyx (ARDX) | 4.6 | $771k | 129k | 5.99 |
|
|
| Fennec Pharmaceuticals (FENC) | 4.1 | $692k | 112k | 6.15 |
|
|
| Benitec Biopharma Com New (BNTC) | 3.9 | $660k | 62k | 10.65 |
|
|
| Sarepta Therapeutics (SRPT) | 3.7 | $620k | 29k | 21.76 |
|
|
| Disc Medicine (IRON) | 3.1 | $518k | 8.1k | 63.94 |
|
|
| Cue Biopharma (CUE) | 3.0 | $506k | 2.2M | 0.23 |
|
|
| Compass Pathways Sponsored Ads (CMPS) | 2.6 | $442k | +37% | 80k | 5.53 |
|
| Biohaven (BHVN) | 2.6 | $437k | 52k | 8.46 |
|
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 2.5 | $417k | 5.5k | 75.85 |
|
|
| Jasper Therapeutics Com New (JSPR) | 2.4 | $407k | 465k | 0.88 |
|
|
| Humacyte (HUMA) | 2.4 | $394k | +30% | 650k | 0.61 |
|
| Viatris (VTRS) | 2.2 | $374k | 28k | 13.51 |
|
|
| Kura Oncology (KURA) | 2.2 | $374k | 46k | 8.13 |
|
|
| Bridgebio Pharma (BBIO) | 2.2 | $371k | 5.0k | 74.26 |
|
|
| Dyne Therapeutics (DYN) | 2.0 | $326k | 18k | 18.13 |
|
|
| Rocket Pharmaceuticals (RCKT) | 1.8 | $308k | 86k | 3.58 |
|
|
| Pacira Pharmaceuticals (PCRX) | 1.8 | $305k | 14k | 22.60 |
|
|
| Edgewise Therapeutics (EWTX) | 1.7 | $287k | 9.1k | 31.50 |
|
|
| Mineralys Therapeutics (MLYS) | 1.7 | $284k | 11k | 27.09 |
|
|
| Seres Therapeutics Com New (MCRB) | 1.7 | $280k | 32k | 8.87 |
|
|
| Janux Therapeutics (JANX) | 1.6 | $264k | 19k | 13.90 |
|
|
| Uniqure Nv SHS (QURE) | 1.4 | $240k | 15k | 16.35 |
|
|
| Regenxbio Inc equity us cm (RGNX) | 1.3 | $223k | 27k | 8.38 |
|
|
| Brooks Automation (AZTA) | 1.2 | $205k | 9.7k | 21.13 |
|
|
| Innoviva (INVA) | 1.1 | $191k | 8.2k | 23.30 |
|
|
| Gh Research Ordinary Shares (GHRS) | 0.9 | $143k | 10k | 14.06 |
|
|
| Arcutis Biotherapeutics (ARQT) | 0.7 | $124k | 5.3k | 23.56 |
|
|
| Innate Pharma S A Sponsored Ads (IPHA) | 0.6 | $104k | 81k | 1.28 |
|
|
| Spruce Biosciences Com New (SPRB) | 0.4 | $65k | 1.0k | 65.35 |
|
Past Filings by Lion Point Capital
SEC 13F filings are viewable for Lion Point Capital going back to 2015
- Lion Point Capital 2026 Q1 filed May 15, 2026
- Lion Point Capital 2025 Q4 filed Feb. 17, 2026
- Lion Point Capital 2025 Q3 filed Nov. 14, 2025
- Lion Point Capital 2025 Q2 filed Aug. 14, 2025
- Lion Point Capital 2025 Q1 filed May 15, 2025
- Lion Point Capital 2024 Q4 filed Feb. 14, 2025
- Lion Point Capital 2024 Q3 filed Nov. 14, 2024
- Lion Point Capital 2024 Q2 filed Aug. 14, 2024
- Lion Point Capital 2024 Q1 filed May 15, 2024
- Lion Point Capital 2023 Q4 filed Feb. 14, 2024
- Lion Point Capital 2023 Q3 filed Nov. 14, 2023
- Lion Point Capital 2023 Q2 filed Aug. 14, 2023
- Lion Point Capital 2023 Q1 filed May 15, 2023
- Lion Point Capital 2022 Q4 filed Feb. 14, 2023
- Lion Point Capital 2022 Q3 filed Nov. 14, 2022
- Lion Point Capital 2022 Q2 filed Aug. 15, 2022